G. Gorzegno

2.5k total citations
51 papers, 1.4k citations indexed

About

G. Gorzegno is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, G. Gorzegno has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 10 papers in Epidemiology. Recurrent topics in G. Gorzegno's work include Bone health and treatments (12 papers), Cancer Treatment and Pharmacology (10 papers) and Neuroendocrine Tumor Research Advances (6 papers). G. Gorzegno is often cited by papers focused on Bone health and treatments (12 papers), Cancer Treatment and Pharmacology (10 papers) and Neuroendocrine Tumor Research Advances (6 papers). G. Gorzegno collaborates with scholars based in Italy, United Kingdom and Germany. G. Gorzegno's co-authors include Luigi Dogliotti, M. Torta, Marco Tampellini, Alfredo Berruti, Alberto Angeli, Alfredo Berruti, Raffaella Bitossi, F. Porpiglia, Dario Fontana and G. Fasolis and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and The Journal of Urology.

In The Last Decade

G. Gorzegno

49 papers receiving 1.4k citations

Peers

G. Gorzegno

ONCOL

PRM

RNMI

NEURO

Adele Caldarella Italy

Markus Raderer Austria

A. Fornasiero Italy

Christophe Leux France

Daniel Keizman Israel

KA MacLennan United Kingdom

Miguel Gil‐Gil Spain

Amir Kurtaran Austria

Michela Donadio Italy

Zsuzsanna Kahán Hungary

Adele Caldarella Italy

G. Gorzegno

499 ×0.6

ONCOL

374 ×0.8

PRM

121 ×0.5

RNMI

240 ×1.0

145 ×0.6

NEURO

Citations per year, relative to G. Gorzegno G. Gorzegno (= 1×) peers Adele Caldarella

Countries citing papers authored by G. Gorzegno

Since Specialization

Citations

This map shows the geographic impact of G. Gorzegno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Gorzegno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Gorzegno more than expected).

Fields of papers citing papers by G. Gorzegno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Gorzegno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Gorzegno. The network helps show where G. Gorzegno may publish in the future.

Co-authorship network of co-authors of G. Gorzegno

This figure shows the co-authorship network connecting the top 25 collaborators of G. Gorzegno. A scholar is included among the top collaborators of G. Gorzegno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Gorzegno. G. Gorzegno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sperone, Paola, et al.. (2020). Systemic recurrence of endometrial cancer more than 10 years after hysterectomy: a report of two cases and a brief review of the literature. Journal of the Egyptian National Cancer Institute. 32(1). 41–41. 6 indexed citations

Gorzegno, G., et al.. (2019). Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment. Gynecologic Oncology Reports. 28. 44–46. 2 indexed citations

Ostacoli, Luca, Andrea Saini, Luigi Ferini‐Strambi, et al.. (2010). Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy. Quality of Life Research. 19(4). 531–537. 31 indexed citations

Sperone, Paola, Alfredo Berruti, G. Gorzegno, et al.. (2006). Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane. Journal of Endocrinological Investigation. 29(6). 560–562. 8 indexed citations

Saini, Andrea, Alfredo Berruti, Paola Sperone, et al.. (2006). Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation. The Lancet Oncology. 7(2). 186–187. 5 indexed citations

Berruti, Alfredo, Raffaella Bitossi, G. Gorzegno, et al.. (2005). Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines. British Journal of Cancer. 92(4). 634–638. 8 indexed citations

Berruti, Alfredo, Marco Tucci, Alessandra Mosca, et al.. (2005). Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease. British Journal of Cancer. 93(6). 633–638. 52 indexed citations

Tucci, Marcello, R. Tarabuzzi, Alessandra Mosca, et al.. (2005). Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: A phase II study with a 5-year follow-up. Urologic Oncology Seminars and Original Investigations. 23(1). 1–7. 12 indexed citations

Berruti, Alfredo, Marcello Tucci, Carlo Terrone, et al.. (2002). Background to and Management of Treatment-Related Bone Loss in Prostate Cancer. Drugs & Aging. 19(12). 899–910. 16 indexed citations

10.

Berruti, Alfredo, M. Torta, A Termine, et al.. (2001). Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience. Annals of Oncology. 12. S73–S77. 51 indexed citations

11.

Donadio, Michela, Alfredo Berruti, Alberto Bottini, et al.. (2001). Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial. Cancer Chemotherapy and Pharmacology. 47(5). 391–396. 8 indexed citations

12.

Tampellini, Marco, Alfredo Berruti, G. Gorzegno, et al.. (2001). Independent Factors Predict Supranormal CA 15-3 Serum Levels in Advanced Breast Cancer Patients at First Disease Relapse. Tumor Biology. 22(6). 367–373. 14 indexed citations

13.

Berruti, Alfredo, Luigi Dogliotti, Alessandra Mosca, et al.. (2001). Potential clinical value of circulating chromogranin A in patients with prostate carcinoma. Annals of Oncology. 12. S153–S157. 38 indexed citations

14.

Bottini, Alberto, Alfredo Berruti, Alessandra Bersiga, et al.. (2000). p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.. PubMed. 6(7). 2751–8. 103 indexed citations

15.

Berruti, Alfredo, Luigi Dogliotti, G. Gorzegno, et al.. (1999). Differential Patterns of Bone Turnover in Relation to Bone Pain and Disease Extent in Bone in Cancer Patients with Skeletal Metastases. Clinical Chemistry. 45(8). 1240–1247. 93 indexed citations

16.

Berruti, Alfredo, P. Borasio, Aldo Gerbino, et al.. (1999). Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience. British Journal of Cancer. 81(5). 841–845. 57 indexed citations

17.

Piovesan, Alessandro, Alfredo Berruti, M. Torta, et al.. (1997). Comparison of Assay of Total and Bone-Specific Alkaline Phosphatase in the Assessment of Osteoblast Activity in Patients with Metastatic Bone Disease. Calcified Tissue International. 61(5). 362–369. 11 indexed citations

18.

Bretti, S., Alfredo Berruti, G. Gorzegno, et al.. (1996). Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients. Lung Cancer. 14(2-3). 353–360. 14 indexed citations

19.

Berruti, Alfredo, et al.. (1994). Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease. European Journal of Cancer. 30(14). 2082–2084. 73 indexed citations

20.

Berruti, Alfredo, et al.. (1993). Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: Results in six patients. Annals of Oncology. 4(5). 429–431. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact